Olmesafe 10 Tablet
By Olmesafe
Rx
10 Tablet in a Strip

Composition
Olmesartan Medoxomil(10mg)

Manufacturer - Aristo Pharmaceuticals Pvt Ltd
Mercantile Chamber, 3rd Floor, 12, J.N. Heredia Marg, Ballard Estate, Mumbai – 400 001, India.

Expires on or after
August, 2025

liver
It is important to use Olmesafe 10 Tablet cautiously in individuals with severe liver disease. In such cases, it may be necessary to adjust the dosage of the medication. It is advisable to consult your doctor before using Olmesafe 10 Tablet if you have severe liver issues. However, no dose adjustment is typically required for patients with mild liver disease. Always seek guidance from your healthcare provider to ensure the safe and appropriate use of Olmesafe 10 Tablet in relation to liver conditions.

kidney
**** Olmesafe 10 Tablet should be used carefully in patients with kidney disease. Dosage adjustment may be necessary; consult your doctor. Regular blood pressure monitoring is recommended for dosage adjustments. Avoid using Olmesafe 10 Tablet in severe kidney disease cases.

alcohol
When taking Olmesafe 10 Tablet, be cautious as it may lead to increased drowsiness when consumed with alcohol.

driving
Olmesafe 10 Tablet may reduce alertness, impact vision, and cause drowsiness or dizziness. Avoid driving if experiencing these effects.

pregnancy
Olmesafe 10 Tablet is considered unsafe during pregnancy due to the definite risk to the developing baby. In life-threatening situations, a doctor may prescribe it only if the benefits outweigh the potential risks. Please consult your doctor before use.

breastfeeding
Olmesafe 10 Tablet is deemed unsafe during breastfeeding. Limited data indicates potential transfer of the drug into breastmilk, posing a risk to the baby.
Habit Forming | No |
Chemical Class | Synthetic imidazole derivative |
Therapeutic Class | CARDIAC |
Action Class | Angiotensin receptor blockers(ARB) |
₹65.9
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024